The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:

"
Rhodopsin 7-helix transmembrane proteins
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 19: Lutropin-choriogonadotropic hormone receptor

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 39 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Follicle-stimulating hormone receptor activity GO:0004963
Combining with follicle-stimulating hormone to initiate a change in cell activity.
15 F8UV77 (/ISS) P32212 (/ISS) P35376 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS) Q6R6L8 (/ISS) Q6R6L8 (/ISS)
(5 more)
Follicle-stimulating hormone receptor activity GO:0004963
Combining with follicle-stimulating hormone to initiate a change in cell activity.
9 A0A2R8RSR3 (/IDA) F1R4X9 (/IDA) P20395 (/IDA) P23945 (/IDA) P35378 (/IDA) P35378 (/IDA) Q6TCF9 (/IDA) Q7ZZC0 (/IDA) Q98T84 (/IDA)
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
8 P14763 (/ISS) P21463 (/ISS) P47750 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Luteinizing hormone receptor activity GO:0004964
Combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity.
7 O02721 (/ISS) P16235 (/ISS) P16582 (/ISS) P16582 (/ISS) P30730 (/ISS) Q28005 (/ISS) Q28585 (/ISS)
Thyroid-stimulating hormone receptor activity GO:0004996
Combining with thyroid-stimulating hormone to initiate a change in cell activity.
7 P14763 (/ISS) P21463 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
7 P14763 (/ISS) P21463 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Luteinizing hormone receptor activity GO:0004964
Combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity.
5 B3DGM7 (/IDA) B8JME5 (/IDA) Q5UK77 (/IDA) Q6TCF8 (/IDA) Q90674 (/IDA)
Luteinizing hormone receptor activity GO:0004964
Combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity.
3 P22888 (/IMP) Q71MM9 (/IMP) Q7T027 (/IMP)
Thyroid-stimulating hormone receptor activity GO:0004996
Combining with thyroid-stimulating hormone to initiate a change in cell activity.
3 C0SKM5 (/IDA) F1Q981 (/IDA) P47750 (/IDA)
Thyroid-stimulating hormone receptor activity GO:0004996
Combining with thyroid-stimulating hormone to initiate a change in cell activity.
3 P16473 (/IMP) P21463 (/IMP) Q6QMG1 (/IMP)
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
3 P16473 (/IPI) P20395 (/IPI) P23945 (/IPI)
Peptide hormone binding GO:0017046
Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
3 P30730 (/ISO) P35378 (/ISO) P35378 (/ISO)
Choriogonadotropin hormone binding GO:0038106
Interacting selectively and non-covalently with choriogonadotropin hormone, a heterodimer, with an alpha subunit identical to that of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH), and a unique beta subunit.
3 F8UV77 (/ISS) P22888 (/ISS) Q9PW16 (/ISS)
Follicle-stimulating hormone receptor activity GO:0004963
Combining with follicle-stimulating hormone to initiate a change in cell activity.
2 P23945 (/IMP) Q98T84 (/IMP)
Follicle-stimulating hormone receptor activity GO:0004963
Combining with follicle-stimulating hormone to initiate a change in cell activity.
2 P35378 (/ISO) P35378 (/ISO)
Peptide hormone binding GO:0017046
Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
2 P16235 (/IDA) P20395 (/IDA)
Choriogonadotropin hormone binding GO:0038106
Interacting selectively and non-covalently with choriogonadotropin hormone, a heterodimer, with an alpha subunit identical to that of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH), and a unique beta subunit.
2 P30730 (/IDA) Q98T84 (/IDA)
G protein-coupled receptor activity GO:0004930
Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
1 P20395 (/TAS)
Luteinizing hormone receptor activity GO:0004964
Combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity.
1 P30730 (/ISO)
Luteinizing hormone receptor activity GO:0004964
Combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity.
1 P30730 (/TAS)
Thyroid-stimulating hormone receptor activity GO:0004996
Combining with thyroid-stimulating hormone to initiate a change in cell activity.
1 P47750 (/ISO)
Thyroid-stimulating hormone receptor activity GO:0004996
Combining with thyroid-stimulating hormone to initiate a change in cell activity.
1 P16473 (/TAS)
G protein-coupled peptide receptor activity GO:0008528
Combining with a peptide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
1 P16235 (/IDA)
G protein-coupled peptide receptor activity GO:0008528
Combining with a peptide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
1 P30730 (/ISO)
Peptide hormone binding GO:0017046
Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
1 P16235 (/IMP)
Peptide hormone binding GO:0017046
Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
1 P16235 (/IPI)
Choriogonadotropin hormone receptor activity GO:0035472
Combining with the choriogonadotropin hormone to initiate a change in cell activity.
1 P30730 (/IDA)
Choriogonadotropin hormone receptor activity GO:0035472
Combining with the choriogonadotropin hormone to initiate a change in cell activity.
1 P30730 (/IMP)
Choriogonadotropin hormone receptor activity GO:0035472
Combining with the choriogonadotropin hormone to initiate a change in cell activity.
1 P22888 (/ISS)
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
1 P16473 (/IMP)
Signaling receptor activity GO:0038023
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
1 P47750 (/ISO)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
1 P16235 (/IDA)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
1 P30730 (/ISO)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
1 P16235 (/IDA)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
1 P30730 (/ISO)
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
1 P16473 (/IDA)
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
1 P47750 (/ISO)
ATPase binding GO:0051117
Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
1 P16235 (/IPI)
ATPase binding GO:0051117
Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
1 P30730 (/ISO)

There are 147 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Regulation of protein kinase A signaling GO:0010738
Any process that modulates the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.
16 P20395 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS)
(6 more)
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
16 P20395 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS)
(6 more)
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
16 P20395 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS)
(6 more)
Cellular response to follicle-stimulating hormone stimulus GO:0071372
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
16 P20395 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS)
(6 more)
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
13 P32212 (/ISS) P35376 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS) Q6R6L8 (/ISS) Q6R6L8 (/ISS) Q6YNB6 (/ISS)
(3 more)
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
13 P32212 (/ISS) P35376 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS) Q6R6L8 (/ISS) Q6R6L8 (/ISS) Q6YNB6 (/ISS)
(3 more)
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
9 P14763 (/ISS) P21463 (/ISS) P22888 (/ISS) P47750 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
9 A0A2R8RSR3 (/IMP) B3DGM7 (/IMP) B8JME5 (/IMP) F1R4X9 (/IMP) P30730 (/IMP) Q5UK77 (/IMP) Q6TCF8 (/IMP) Q6TCF9 (/IMP) Q7ZZC0 (/IMP)
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
8 P14763 (/ISS) P21463 (/ISS) P47750 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
8 A0A2R8RSR3 (/IGI) B3DGM7 (/IGI) B8JME5 (/IGI) F1R4X9 (/IGI) Q5UK77 (/IGI) Q6TCF8 (/IGI) Q6TCF9 (/IGI) Q7ZZC0 (/IGI)
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
8 A0A2R8RSR3 (/IGI) B3DGM7 (/IGI) B8JME5 (/IGI) F1R4X9 (/IGI) Q5UK77 (/IGI) Q6TCF8 (/IGI) Q6TCF9 (/IGI) Q7ZZC0 (/IGI)
Cellular response to luteinizing hormone stimulus GO:0071373
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
8 O02721 (/ISS) P16235 (/ISS) P16582 (/ISS) P16582 (/ISS) P30730 (/ISS) Q28005 (/ISS) Q28585 (/ISS) Q90674 (/ISS)
Cellular response to glycoprotein GO:1904588
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glycoprotein stimulus.
8 P14763 (/ISS) P21463 (/ISS) P47750 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Cellular response to thyrotropin-releasing hormone GO:1905229
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyrotropin-releasing hormone (TRH) stimulus. TRH increases the secretion of thyroid-stimulating hormone by the anterior pituitary.
8 P14763 (/ISS) P21463 (/ISS) P47750 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
7 A0A2R8RSR3 (/IMP) F1R4X9 (/IMP) P30730 (/IMP) P35378 (/IMP) P35378 (/IMP) Q6TCF9 (/IMP) Q7ZZC0 (/IMP)
Thyroid-stimulating hormone signaling pathway GO:0038194
The series of molecular signals generated as a consequence of thyroid-stimulating hormone (thyrotropin) binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.
7 P14763 (/ISS) P21463 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Luteinizing hormone signaling pathway GO:0042700
The series of molecular signals mediated by luteinizing hormone.
6 O02721 (/ISS) P16582 (/ISS) P16582 (/ISS) P30730 (/ISS) Q28005 (/ISS) Q28585 (/ISS)
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
5 A0A2R8RSR3 (/IMP) F1R4X9 (/IMP) P30730 (/IMP) Q6TCF9 (/IMP) Q7ZZC0 (/IMP)
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
4 P20395 (/IDA) P30730 (/IDA) P47750 (/IDA) Q90674 (/IDA)
Phospholipase C-activating G protein-coupled receptor signaling pathway GO:0007200
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG).
4 P16235 (/IDA) P30730 (/IDA) P35378 (/IDA) P35378 (/IDA)
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
4 P30730 (/IMP) P35378 (/IMP) P35378 (/IMP) Q71MM9 (/IMP)
Ovulation GO:0030728
The release of a mature ovum/oocyte from an ovary.
4 B3DGM7 (/IMP) B8JME5 (/IMP) Q5UK77 (/IMP) Q6TCF8 (/IMP)
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
4 P20395 (/IDA) P23945 (/IDA) P35378 (/IDA) P35378 (/IDA)
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
3 P16473 (/TAS) P22888 (/TAS) P23945 (/TAS)
Adenylate cyclase-modulating G protein-coupled receptor signaling pathway GO:0007188
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation or inhibition of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP (cAMP).
3 P16235 (/IDA) P35378 (/IDA) P35378 (/IDA)
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
3 P35378 (/ISO) P35378 (/ISO) P47750 (/ISO)
Ovulation cycle process GO:0022602
A process involved in the sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
3 P30730 (/IMP) P35378 (/IMP) P35378 (/IMP)
Uterus development GO:0060065
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
3 P30730 (/IMP) P35378 (/IMP) P35378 (/IMP)
Positive regulation of cold-induced thermogenesis GO:0120162
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis.
3 G3V6J1 (/ISS) P16473 (/ISS) P21463 (/ISS)
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
2 C0SKM5 (/IMP) F1Q981 (/IMP)
Primary ovarian follicle growth GO:0001545
Increase in size of primary follicles including oocyte growth and granulosa and/or theca cell proliferation until more than one layer of granulosa cells is present (preantral follicle).
2 P35378 (/IMP) P35378 (/IMP)
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
2 P35378 (/IMP) P35378 (/IMP)
Regulation of systemic arterial blood pressure GO:0003073
The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
2 P35378 (/IMP) P35378 (/IMP)
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
2 P35378 (/ISO) P35378 (/ISO)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger GO:0007187
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds with activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide.
2 P16473 (/TAS) P22888 (/TAS)
Activation of adenylate cyclase activity GO:0007190
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
2 P16235 (/IDA) P30730 (/IDA)
Adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway GO:0007193
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP).
2 P35378 (/IDA) P35378 (/IDA)
Spermatid development GO:0007286
The process whose specific outcome is the progression of a spermatid over time, from its formation to the mature structure.
2 P35378 (/IMP) P35378 (/IMP)
Locomotory behavior GO:0007626
The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions.
2 P35378 (/IMP) P35378 (/IMP)
Cellular water homeostasis GO:0009992
Any process involved in the maintenance of an internal steady state of water within a cell.
2 P35378 (/IMP) P35378 (/IMP)
Regulation of platelet-derived growth factor receptor signaling pathway GO:0010640
Any process that modulates the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.
2 P35378 (/IMP) P35378 (/IMP)
Regulation of protein kinase A signaling GO:0010738
Any process that modulates the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.
2 P35378 (/ISO) P35378 (/ISO)
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
2 P35378 (/ISO) P35378 (/ISO)
Neuron projection development GO:0031175
The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
2 P35378 (/IMP) P35378 (/IMP)
Regulation of hormone metabolic process GO:0032350
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
2 P35378 (/IMP) P35378 (/IMP)
Response to follicle-stimulating hormone GO:0032354
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
2 Q71MM9 (/IMP) Q98T84 (/IMP)
Regulation of chromosome organization GO:0033044
Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a chromosome.
2 P35378 (/IMP) P35378 (/IMP)
Regulation of intracellular estrogen receptor signaling pathway GO:0033146
Any process that modulates the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.
2 P35378 (/IMP) P35378 (/IMP)
Positive regulation of intracellular estrogen receptor signaling pathway GO:0033148
Any process that activates or increases the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.
2 P35378 (/IMP) P35378 (/IMP)
Response to luteinizing hormone GO:0034699
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
2 Q71MM9 (/IMP) Q7T027 (/IMP)
Sperm chromatin condensation GO:0035092
The progressive compaction of the spermatid chromatin so that it reaches a level of condensation that is not compatible with nuclear activities such as transcription or DNA replication.
2 P35378 (/IMP) P35378 (/IMP)
Spermatogenesis, exchange of chromosomal proteins GO:0035093
The replacement of somatic histones within sperm chromatin with sperm-specific histones or protamines with unique DNA-binding properties, resulting in condensation of the sperm chromatin.
2 P35378 (/IMP) P35378 (/IMP)
Thyroid-stimulating hormone signaling pathway GO:0038194
The series of molecular signals generated as a consequence of thyroid-stimulating hormone (thyrotropin) binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.
2 P16473 (/IMP) Q6QMG1 (/IMP)
Positive regulation of multicellular organism growth GO:0040018
Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
2 P47750 (/IMP) Q71MM9 (/IMP)
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
2 P23945 (/IMP) P35379 (/IMP)
Follicle-stimulating hormone signaling pathway GO:0042699
The series of molecular signals mediated by follicle-stimulating hormone.
2 P35378 (/ISO) P35378 (/ISO)
Luteinizing hormone signaling pathway GO:0042700
The series of molecular signals mediated by luteinizing hormone.
2 P16235 (/IDA) Q90674 (/IDA)
Regulation of MAPK cascade GO:0043408
Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade.
2 P35378 (/IMP) P35378 (/IMP)
Transcytosis GO:0045056
The directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side.
2 P35378 (/ISO) P35378 (/ISO)
Regulation of osteoclast differentiation GO:0045670
Any process that modulates the frequency, rate or extent of osteoclast differentiation.
2 P35378 (/IMP) P35378 (/IMP)
Negative regulation of bone resorption GO:0045779
Any process that stops, prevents, or reduces the frequency, rate or extent of bone resorption.
2 P35378 (/IMP) P35378 (/IMP)
Sertoli cell development GO:0060009
The process whose specific outcome is the progression of a Sertoli cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a Sertoli cell fate.
2 P35378 (/IMP) P35378 (/IMP)
Sertoli cell proliferation GO:0060011
The multiplication or reproduction of Sertoli cells, resulting in the expansion of the Sertoli cell population. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
2 P35378 (/IMP) P35378 (/IMP)
Regulation of acetylcholine metabolic process GO:0060408
Any process that modulates the rate, frequency or extent of the chemical reactions and pathways involving acetylcholine, the acetic acid ester of the organic base choline. Acetylcholine is a major neurotransmitter and neuromodulator both in the central and peripheral nervous systems. It also acts as a paracrine signal in various non-neural tissues.
2 P35378 (/IGI) P35378 (/IGI)
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
2 P35378 (/ISO) P35378 (/ISO)
Cellular response to follicle-stimulating hormone stimulus GO:0071372
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
2 P35378 (/ISO) P35378 (/ISO)
Basement membrane organization GO:0071711
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the basement membrane.
2 P35378 (/IMP) P35378 (/IMP)
Protein targeting to lysosome GO:0006622
The process of directing proteins towards the lysosome using signals contained within the protein.
1 P16235 (/IMP)
Protein targeting to lysosome GO:0006622
The process of directing proteins towards the lysosome using signals contained within the protein.
1 P30730 (/ISO)
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
1 P16473 (/IMP)
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
1 P47750 (/ISO)
G protein-coupled receptor signaling pathway GO:0007186
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).
1 P23945 (/IDA)
Adenylate cyclase-modulating G protein-coupled receptor signaling pathway GO:0007188
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation or inhibition of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP (cAMP).
1 P16235 (/IMP)
Adenylate cyclase-modulating G protein-coupled receptor signaling pathway GO:0007188
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation or inhibition of adenylyl cyclase activity and a subsequent change in the concentration of cyclic AMP (cAMP).
1 P30730 (/ISO)
Adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds through activation of adenylyl cyclase activity and a subsequent increase in the concentration of cyclic AMP (cAMP).
1 P16473 (/IMP)
Activation of adenylate cyclase activity GO:0007190
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
1 P30730 (/ISO)
Activation of adenylate cyclase activity GO:0007190
Any process that initiates the activity of the inactive enzyme adenylate cyclase.
1 P22888 (/ISS)
Phospholipase C-activating G protein-coupled receptor signaling pathway GO:0007200
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG).
1 P30730 (/ISO)
Phospholipase C-activating G protein-coupled receptor signaling pathway GO:0007200
The series of molecular signals generated as a consequence of a G protein-coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG).
1 P22888 (/ISS)
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
1 P16473 (/TAS)
Gamete generation GO:0007276
The generation and maintenance of gametes in a multicellular organism. A gamete is a haploid reproductive cell.
1 Q6QMG1 (/IEP)
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
1 P23945 (/TAS)
Female gamete generation GO:0007292
Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.
1 P23945 (/TAS)
Central nervous system development GO:0007417
The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
1 P16235 (/IEP)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 P21463 (/IDA)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 P47750 (/ISO)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 P16473 (/TAS)
Adult locomotory behavior GO:0008344
Locomotory behavior in a fully developed and mature organism.
1 P47750 (/IMP)
Gonad development GO:0008406
The process whose specific outcome is the progression of the gonad over time, from its formation to the mature structure. The gonad is an animal organ that produces gametes; in some species it also produces hormones.
1 P23945 (/TAS)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
1 P23945 (/IEP)
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
1 P22888 (/TAS)
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
1 P23945 (/TAS)
Hormone-mediated signaling pathway GO:0009755
A series of molecular signals mediated by the detection of a hormone.
1 P16235 (/IDA)
Hormone-mediated signaling pathway GO:0009755
A series of molecular signals mediated by the detection of a hormone.
1 P30730 (/ISO)
Positive regulation of calcium ion transport into cytosol GO:0010524
Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
1 P16235 (/IDA)
Positive regulation of calcium ion transport into cytosol GO:0010524
Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
1 P30730 (/ISO)
Regulation of protein kinase A signaling GO:0010738
Any process that modulates the rate, frequency, or extent of protein kinase A signaling. PKA signaling is the series of reactions, mediated by the intracellular serine/threonine kinase protein kinase A, which occurs as a result of a single trigger reaction or compound.
1 P23945 (/IMP)
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
1 P23945 (/IMP)
B cell differentiation GO:0030183
The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
1 P47750 (/IMP)
Male genitalia development GO:0030539
The process whose specific outcome is the progression of the male genitalia over time, from its formation to the mature structure.
1 P22888 (/TAS)
Positive regulation of inositol trisphosphate biosynthetic process GO:0032962
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.
1 P30730 (/IDA)
Positive regulation of inositol trisphosphate biosynthetic process GO:0032962
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.
1 P22888 (/ISS)
Positive regulation of luteinizing hormone secretion GO:0033686
Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.
1 P79763 (/IEP)
Response to luteinizing hormone GO:0034699
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
1 P16235 (/IDA)
Response to luteinizing hormone GO:0034699
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
1 P30730 (/ISO)
Thyroid-stimulating hormone signaling pathway GO:0038194
The series of molecular signals generated as a consequence of thyroid-stimulating hormone (thyrotropin) binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstream cellular process, e.g. transcription.
1 P47750 (/ISO)
Regulation of locomotion GO:0040012
Any process that modulates the frequency, rate or extent of locomotion of a cell or organism.
1 P47750 (/IMP)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
1 P16235 (/IEP)
Luteinizing hormone signaling pathway GO:0042700
The series of molecular signals mediated by luteinizing hormone.
1 P22888 (/IMP)
Luteinizing hormone signaling pathway GO:0042700
The series of molecular signals mediated by luteinizing hormone.
1 P30730 (/ISO)
Response to human chorionic gonadotropin GO:0044752
Any process that results in a change in state or activity of a cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a human chorionic gonadotropin stimulus.
1 Q6QMG1 (/IMP)
Transcytosis GO:0045056
The directed movement of endocytosed material through the cell and its exocytosis from the plasma membrane at the opposite side.
1 P20395 (/IDA)
Development of secondary male sexual characteristics GO:0046544
The process whose specific outcome is the progression of the secondary male sexual characteristics over time, from their formation to the mature structures. In male humans, these include growth of axillary, chest, and pubic hair, voice changes, and testicular/penile enlargement. Development occurs in response to sex hormone secretion.
1 P30730 (/IMP)
Positive regulation of hormone biosynthetic process GO:0046886
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.
1 P16235 (/IDA)
Positive regulation of hormone biosynthetic process GO:0046886
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.
1 P30730 (/ISO)
Arachidonic acid secretion GO:0050482
The controlled release of arachidonic acid from a cell or a tissue.
1 P16235 (/IDA)
Arachidonic acid secretion GO:0050482
The controlled release of arachidonic acid from a cell or a tissue.
1 P30730 (/ISO)
Regulation of steroid biosynthetic process GO:0050810
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
1 P16235 (/IEP)
Positive regulation of calcium-mediated signaling GO:0050850
Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling.
1 P16235 (/IDA)
Positive regulation of calcium-mediated signaling GO:0050850
Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling.
1 P30730 (/ISO)
Cognition GO:0050890
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
1 P22888 (/IMP)
Cognition GO:0050890
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
1 P30730 (/ISO)
Positive regulation of release of sequestered calcium ion into cytosol GO:0051281
Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
1 P16235 (/IDA)
Positive regulation of release of sequestered calcium ion into cytosol GO:0051281
Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
1 P30730 (/ISO)
Inner ear receptor cell development GO:0060119
The process whose specific outcome is the progression of an inner ear receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
1 P47750 (/IMP)
Inner ear receptor cell stereocilium organization GO:0060122
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of inner ear receptor cells.
1 P47750 (/IMP)
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
1 P23945 (/IDA)
Cellular response to gonadotropin stimulus GO:0071371
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
1 P30730 (/IDA)
Cellular response to gonadotropin stimulus GO:0071371
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
1 P22888 (/ISS)
Cellular response to follicle-stimulating hormone stimulus GO:0071372
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
1 P23945 (/IMP)
Cellular response to luteinizing hormone stimulus GO:0071373
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
1 P22888 (/IMP)
Cellular response to luteinizing hormone stimulus GO:0071373
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
1 P30730 (/ISO)
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
1 P47750 (/IMP)
Seminiferous tubule development GO:0072520
The reproductive developmental process whose specific outcome is the progression of the seminiferous tubule over time, from its formation to the mature structure. Seminiferous tubules are ducts located in the testicles, and are the specific location of meiosis, and the subsequent creation of gametes, namely spermatozoa.
1 P30730 (/IMP)
Regulation of steroid hormone biosynthetic process GO:0090030
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroid hormones,compounds with a 1, 2, cyclopentanoperhydrophenanthrene nucleus that act as hormones.
1 P30730 (/IMP)
Cochlea morphogenesis GO:0090103
The process in which the cochlea is generated and organized.
1 P47750 (/IMP)
Response to thyroid hormone GO:0097066
A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
1 Q6QMG1 (/IMP)
Positive regulation of cold-induced thermogenesis GO:0120162
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis.
1 P47750 (/IMP)
Positive regulation of vitellogenesis GO:1903188
Any process that activates or increases the frequency, rate or extent of vitellogenesis.
1 Q71MM9 (/IMP)
Cellular response to glycoprotein GO:1904588
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glycoprotein stimulus.
1 P16473 (/IMP)
Cellular response to glycoprotein GO:1904588
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glycoprotein stimulus.
1 P47750 (/ISO)
Cellular response to thyrotropin-releasing hormone GO:1905229
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyrotropin-releasing hormone (TRH) stimulus. TRH increases the secretion of thyroid-stimulating hormone by the anterior pituitary.
1 P16473 (/IMP)
Cellular response to thyrotropin-releasing hormone GO:1905229
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyrotropin-releasing hormone (TRH) stimulus. TRH increases the secretion of thyroid-stimulating hormone by the anterior pituitary.
1 P47750 (/ISO)
Positive regulation of male gonad development GO:2000020
Any process that activates or increases the frequency, rate or extent of male gonad development.
1 Q71MM9 (/IMP)
Positive regulation of female gonad development GO:2000196
Any process that activates or increases the frequency, rate or extent of female gonad development.
1 Q71MM9 (/IMP)
Positive regulation of testosterone secretion GO:2000845
Any process that activates or increases the frequency, rate or extent of testosterone secretion.
1 Q71MM9 (/IMP)
Positive regulation of estradiol secretion GO:2000866
Any process that activates or increases the frequency, rate or extent of estradiol secretion.
1 Q71MM9 (/IMP)

There are 41 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
29 O02721 (/ISS) P14763 (/ISS) P16582 (/ISS) P16582 (/ISS) P20395 (/ISS) P21463 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS)
(19 more)
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
16 P20395 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS)
(6 more)
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
16 P20395 (/ISS) P32212 (/ISS) P35376 (/ISS) P35378 (/ISS) P35378 (/ISS) P35379 (/ISS) P47799 (/ISS) P49059 (/ISS) P79763 (/ISS) Q5GJ04 (/ISS)
(6 more)
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
8 P14763 (/ISS) P21463 (/ISS) P47750 (/ISS) P56495 (/ISS) Q27987 (/ISS) Q6QMG1 (/ISS) Q8SPP9 (/ISS) Q9BGN4 (/ISS)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
5 P16235 (/IDA) P16473 (/IDA) P22888 (/IDA) P23945 (/IDA) P47750 (/IDA)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
4 P30730 (/ISO) P35378 (/ISO) P35378 (/ISO) P47750 (/ISO)
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
4 P30730 (/ISO) P35378 (/ISO) P35378 (/ISO) P47750 (/ISO)
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
3 P30730 (/ISO) P35378 (/ISO) P35378 (/ISO)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
3 P16473 (/TAS) P22888 (/TAS) P23945 (/TAS)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
3 P20395 (/IDA) P35378 (/IDA) P35378 (/IDA)
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
3 Q71MM9 (/IC) Q7T027 (/IC) Q98T84 (/IC)
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
3 P16235 (/IDA) P16473 (/IDA) P23945 (/IDA)
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
2 P16235 (/IDA) P20395 (/IDA)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
2 P16235 (/IDA) P30730 (/IDA)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
2 P16473 (/TAS) P22888 (/TAS)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
2 P35378 (/ISO) P35378 (/ISO)
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
2 Q6QMG1 (/IDA) Q98T84 (/IDA)
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
2 F8UV77 (/ISS) Q9PW16 (/ISS)
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
2 P35378 (/ISO) P35378 (/ISO)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 P16235 (/IDA)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 P30730 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 P16235 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 P30730 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
1 P16235 (/IDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
1 P30730 (/ISO)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
1 P16235 (/IDA)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
1 P30730 (/ISO)
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
1 P22888 (/TAS)
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
1 P16235 (/IDA)
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
1 P30730 (/ISO)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
1 P30730 (/ISO)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
1 P22888 (/ISS)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
1 P16473 (/ISS)
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
1 P23945 (/IDA)
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
1 P23945 (/TAS)
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
1 P16473 (/IDA)
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
1 P47750 (/ISO)
Intrinsic component of external side of plasma membrane GO:0031233
The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
1 P16235 (/IDA)
Intrinsic component of external side of plasma membrane GO:0031233
The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
1 P30730 (/ISO)
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
1 P21463 (/IDA)
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
1 P47750 (/ISO)
CATH-Gene3D is a Global Biodata Core Resource Learn more...